Global Next-Generation Biologics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Next generation biologics refers to some noval drugs, biotreatment and some breakthroght biomaterials etc.
Scope of the Report:
This report studies the Next-Generation Biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next-Generation Biologics market by product type and applications/end industries.
The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to an mAbs. These drugs have shown to be potent and efficient in treating diseases, including cancers and hematological malignancies.
The global Next-Generation Biologics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next-Generation Biologics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Scope of the Report:
This report studies the Next-Generation Biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next-Generation Biologics market by product type and applications/end industries.
The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to an mAbs. These drugs have shown to be potent and efficient in treating diseases, including cancers and hematological malignancies.
The global Next-Generation Biologics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next-Generation Biologics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Allergan
- Bayer
- Biogen Idec
- Eli Lilly
- Kyowa Hakko Kirin
- Molecular Partners
- Novo Nordisk
- Pfizer
- Roche
- Sanofi
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Antibodies
- Regenerative medicine
- Insulins
- Growth hormones
- Other
- Medical
- Scientific Research
- Other
1 NEXT-GENERATION BIOLOGICS MARKET OVERVIEW
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Classification of Next-Generation Biologics by Types
1.2.1 Global Next-Generation Biologics Revenue Comparison by Types (2017-2023)
1.2.2 Global Next-Generation Biologics Revenue Market Share by Types in 2017
1.2.3 Antibodies
1.2.4 Regenerative medicine
1.2.5 Insulins
1.2.6 Growth hormones
1.2.7 Other
1.3 Global Next-Generation Biologics Market by Application
1.3.1 Global Next-Generation Biologics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Other
1.4 Global Next-Generation Biologics Market by Regions
1.4.1 Global Next-Generation Biologics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next-Generation Biologics Status and Prospect (2013-2023)
1.5 Global Market Size of Next-Generation Biologics (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Allergan
2.1.1 Business Overview
2.1.2 Next-Generation Biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Next-Generation Biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen Idec
2.3.1 Business Overview
2.3.2 Next-Generation Biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Idec Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Next-Generation Biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Kyowa Hakko Kirin
2.5.1 Business Overview
2.5.2 Next-Generation Biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Kyowa Hakko Kirin Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Molecular Partners
2.6.1 Business Overview
2.6.2 Next-Generation Biologics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Molecular Partners Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Next-Generation Biologics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novo Nordisk Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Next-Generation Biologics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Roche
2.9.1 Business Overview
2.9.2 Next-Generation Biologics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Next-Generation Biologics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL NEXT-GENERATION BIOLOGICS MARKET COMPETITION, BY PLAYERS
3.1 Global Next-Generation Biologics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Next-Generation Biologics Players Market Share
3.2.2 Top 10 Next-Generation Biologics Players Market Share
3.3 Market Competition Trend
4 GLOBAL NEXT-GENERATION BIOLOGICS MARKET SIZE BY REGIONS
4.1 Global Next-Generation Biologics Revenue and Market Share by Regions
4.2 North America Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.3 Europe Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.5 South America Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA NEXT-GENERATION BIOLOGICS REVENUE BY COUNTRIES
5.1 North America Next-Generation Biologics Revenue by Countries (2013-2018)
5.2 USA Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5.3 Canada Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5.4 Mexico Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6 EUROPE NEXT-GENERATION BIOLOGICS REVENUE BY COUNTRIES
6.1 Europe Next-Generation Biologics Revenue by Countries (2013-2018)
6.2 Germany Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.3 UK Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.4 France Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.5 Russia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.6 Italy Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC NEXT-GENERATION BIOLOGICS REVENUE BY COUNTRIES
7.1 Asia-Pacific Next-Generation Biologics Revenue by Countries (2013-2018)
7.2 China Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.3 Japan Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.4 Korea Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.5 India Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA NEXT-GENERATION BIOLOGICS REVENUE BY COUNTRIES
8.1 South America Next-Generation Biologics Revenue by Countries (2013-2018)
8.2 Brazil Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8.3 Argentina Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8.4 Colombia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE NEXT-GENERATION BIOLOGICS BY COUNTRIES
9.1 Middle East and Africa Next-Generation Biologics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.3 UAE Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.4 Egypt Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.6 South Africa Next-Generation Biologics Revenue and Growth Rate (2013-2018)
10 GLOBAL NEXT-GENERATION BIOLOGICS MARKET SEGMENT BY TYPE
10.1 Global Next-Generation Biologics Revenue and Market Share by Type (2013-2018)
10.2 Global Next-Generation Biologics Market Forecast by Type (2018-2023)
10.3 Antibodies Revenue Growth Rate (2013-2023)
10.4 Regenerative medicine Revenue Growth Rate (2013-2023)
10.5 Insulins Revenue Growth Rate (2013-2023)
10.6 Growth hormones Revenue Growth Rate (2013-2023)
10.7 Other Revenue Growth Rate (2013-2023)
11 GLOBAL NEXT-GENERATION BIOLOGICS MARKET SEGMENT BY APPLICATION
11.1 Global Next-Generation Biologics Revenue Market Share by Application (2013-2018)
11.2 Next-Generation Biologics Market Forecast by Application (2018-2023)
11.3 Medical Revenue Growth (2013-2018)
11.4 Scientific Research Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 GLOBAL NEXT-GENERATION BIOLOGICS MARKET SIZE FORECAST (2018-2023)
12.1 Global Next-Generation Biologics Market Size Forecast (2018-2023)
12.2 Global Next-Generation Biologics Market Forecast by Regions (2018-2023)
12.3 North America Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.4 Europe Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.6 South America Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Next-Generation Biologics Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Classification of Next-Generation Biologics by Types
1.2.1 Global Next-Generation Biologics Revenue Comparison by Types (2017-2023)
1.2.2 Global Next-Generation Biologics Revenue Market Share by Types in 2017
1.2.3 Antibodies
1.2.4 Regenerative medicine
1.2.5 Insulins
1.2.6 Growth hormones
1.2.7 Other
1.3 Global Next-Generation Biologics Market by Application
1.3.1 Global Next-Generation Biologics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Other
1.4 Global Next-Generation Biologics Market by Regions
1.4.1 Global Next-Generation Biologics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Next-Generation Biologics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next-Generation Biologics Status and Prospect (2013-2023)
1.5 Global Market Size of Next-Generation Biologics (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Allergan
2.1.1 Business Overview
2.1.2 Next-Generation Biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Next-Generation Biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen Idec
2.3.1 Business Overview
2.3.2 Next-Generation Biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Idec Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Next-Generation Biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Kyowa Hakko Kirin
2.5.1 Business Overview
2.5.2 Next-Generation Biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Kyowa Hakko Kirin Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Molecular Partners
2.6.1 Business Overview
2.6.2 Next-Generation Biologics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Molecular Partners Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Next-Generation Biologics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novo Nordisk Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Next-Generation Biologics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Roche
2.9.1 Business Overview
2.9.2 Next-Generation Biologics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Next-Generation Biologics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Next-Generation Biologics Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL NEXT-GENERATION BIOLOGICS MARKET COMPETITION, BY PLAYERS
3.1 Global Next-Generation Biologics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Next-Generation Biologics Players Market Share
3.2.2 Top 10 Next-Generation Biologics Players Market Share
3.3 Market Competition Trend
4 GLOBAL NEXT-GENERATION BIOLOGICS MARKET SIZE BY REGIONS
4.1 Global Next-Generation Biologics Revenue and Market Share by Regions
4.2 North America Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.3 Europe Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.5 South America Next-Generation Biologics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA NEXT-GENERATION BIOLOGICS REVENUE BY COUNTRIES
5.1 North America Next-Generation Biologics Revenue by Countries (2013-2018)
5.2 USA Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5.3 Canada Next-Generation Biologics Revenue and Growth Rate (2013-2018)
5.4 Mexico Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6 EUROPE NEXT-GENERATION BIOLOGICS REVENUE BY COUNTRIES
6.1 Europe Next-Generation Biologics Revenue by Countries (2013-2018)
6.2 Germany Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.3 UK Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.4 France Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.5 Russia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
6.6 Italy Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC NEXT-GENERATION BIOLOGICS REVENUE BY COUNTRIES
7.1 Asia-Pacific Next-Generation Biologics Revenue by Countries (2013-2018)
7.2 China Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.3 Japan Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.4 Korea Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.5 India Next-Generation Biologics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA NEXT-GENERATION BIOLOGICS REVENUE BY COUNTRIES
8.1 South America Next-Generation Biologics Revenue by Countries (2013-2018)
8.2 Brazil Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8.3 Argentina Next-Generation Biologics Revenue and Growth Rate (2013-2018)
8.4 Colombia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE NEXT-GENERATION BIOLOGICS BY COUNTRIES
9.1 Middle East and Africa Next-Generation Biologics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.3 UAE Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.4 Egypt Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Next-Generation Biologics Revenue and Growth Rate (2013-2018)
9.6 South Africa Next-Generation Biologics Revenue and Growth Rate (2013-2018)
10 GLOBAL NEXT-GENERATION BIOLOGICS MARKET SEGMENT BY TYPE
10.1 Global Next-Generation Biologics Revenue and Market Share by Type (2013-2018)
10.2 Global Next-Generation Biologics Market Forecast by Type (2018-2023)
10.3 Antibodies Revenue Growth Rate (2013-2023)
10.4 Regenerative medicine Revenue Growth Rate (2013-2023)
10.5 Insulins Revenue Growth Rate (2013-2023)
10.6 Growth hormones Revenue Growth Rate (2013-2023)
10.7 Other Revenue Growth Rate (2013-2023)
11 GLOBAL NEXT-GENERATION BIOLOGICS MARKET SEGMENT BY APPLICATION
11.1 Global Next-Generation Biologics Revenue Market Share by Application (2013-2018)
11.2 Next-Generation Biologics Market Forecast by Application (2018-2023)
11.3 Medical Revenue Growth (2013-2018)
11.4 Scientific Research Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 GLOBAL NEXT-GENERATION BIOLOGICS MARKET SIZE FORECAST (2018-2023)
12.1 Global Next-Generation Biologics Market Size Forecast (2018-2023)
12.2 Global Next-Generation Biologics Market Forecast by Regions (2018-2023)
12.3 North America Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.4 Europe Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.6 South America Next-Generation Biologics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Next-Generation Biologics Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Next-Generation Biologics Picture
Table Product Specifications of Next-Generation Biologics
Table Global Next-Generation Biologics and Revenue (Million USD) Market Split by Product Type
Fi
Figure Next-Generation Biologics Picture
Table Product Specifications of Next-Generation Biologics
Table Global Next-Generation Biologics and Revenue (Million USD) Market Split by Product Type
Fi
